Life Science Company News

Results 201 - 220 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 14 Jun 2024

ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change

Read more ››
By: GlobeNewswire - 14 Jun 2024

FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Completes Steps it Believes are Required to Regain Compliance

Read more ››
By: GlobeNewswire - 14 Jun 2024

FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE

Read more ››
By: PR Newswire Association LLC. - 14 Jun 2024

MTEC Announces Strategic Leadership Transitions

Read more ››
By: PR Newswire Association LLC. - 14 Jun 2024

Physician Partners of America's Tampa Florida Clinic has Relocated

Read more ››
By: PR Newswire Association LLC. - 14 Jun 2024

AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer

Read more ››
By: PR Newswire Association LLC. - 14 Jun 2024

FDA Roundup: June 14, 2024

Read more ››
By: PR Newswire Association LLC. - 14 Jun 2024

Regroupement des pharmacies de médicaments de spécialité du Québec declaration

Read more ››
By: PR Newswire Association LLC. - 14 Jun 2024

Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit

Read more ››
By: GlobeNewswire - 14 Jun 2024

Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting

Read more ››
By: GlobeNewswire - 14 Jun 2024

Tilray Beverages Announces Campaign to Raise Awareness for Men’s Health

Read more ››
By: GlobeNewswire - 14 Jun 2024

Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress

Read more ››
By: GlobeNewswire - 14 Jun 2024

TScan Therapeutics Announces Updates to its Board of Directors

Read more ››
By: GlobeNewswire - 14 Jun 2024

Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 Variants

Read more ››
By: GlobeNewswire - 14 Jun 2024

Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evaluating Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

Read more ››
By: GlobeNewswire - 14 Jun 2024

Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress

Read more ››
By: GlobeNewswire - 14 Jun 2024

Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective and Surpassed Standard of Care in Treating Hard-to-Treat T-ALL/LBL; Data Presented Today at European Hematology Association (EHA) 2024 Hybrid Congress

Read more ››
By: GlobeNewswire - 14 Jun 2024

Intellia Therapeutics Names Brian Goff to its Board of Directors

Read more ››
By: GlobeNewswire - 14 Jun 2024

Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress

Read more ››
By: GlobeNewswire - 14 Jun 2024
Results 201 - 220 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate